 |
|
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C
Jae Hee Lim, Yun Nah Lee, Young Seok Kim, Sang Gyune Kim, Seung Won Jeong, Jae Young Jang, Hong Soo Kim, Sae Hwan Lee, Tae Kwann Park
Korean J Hepatol. 2011;17(1):61-65. Published online 2011 Mar 21 DOI: https://doi.org/10.3350/kjhep.2011.17.1.61
|
|
Citations to this article as recorded by
 Enfermedad de Vogt Koyanagi Harada. Reporte de un caso y revisión de la literatura
Rodrigo Betancourt, Stefanos A. Betancourt, Germán Soler, Rubén D. Mantilla, Gabriel A. Castillo
Revista Colombiana de Reumatología.2020; 27(1): 50. CrossRef Vogt-Koyanagi-Harada disease. Case report and review of the literature
Rodrigo Betancourt, Stefanos A. Betancourt, Germán Soler, Rubén D. Mantilla, Gabriel A. Castillo
Revista Colombiana de Reumatología (English Edition).2020; 27(1): 50. CrossRef Ocular side effects of antirheumatic medications: a qualitative review
Clara M Castillejo Becerra, Yue Ding, Beatrice Kenol, Andrew Hendershot, Alexa Simon Meara
BMJ Open Ophthalmology.2020; 5(1): e000331. CrossRef Induction of Vogt-Koyanagi-Harada Disease by Interferon-Alpha and Ribavirin Treatment in Patients with Hepatitis C: A Case Report and Review of the Literature
Jialiang Duan, Yang Wang, Danyan Liu, Jingxue Ma
Ocular Immunology and Inflammation.2019; 27(2): 229. CrossRef Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature
Ken Sato, Yuichi Yamazaki, Takeshi Kobayashi, Satoshi Takakusagi, Norio Horiguchi, Satoru Kakizaki, Masayasu Andou, Yoshihiro Matsuda, Toshio Uraoka, Hiroshi Ohnishi, Hiroaki Okamoto
World Journal of Clinical Cases.2019; 7(9): 1043. CrossRef Vogt-Koyanagi-Harada disease
Ghazala A. Datoo O'Keefe, Narsing A. Rao
Survey of Ophthalmology.2017; 62(1): 1. CrossRef Exudative retinal detachment
Radgonde Amer, Hilal Nalcı, Nilüfer Yalçındağ
Survey of Ophthalmology.2017; 62(6): 723. CrossRef Vogt–Koyanagi–Harada syndrome: Perspectives for immunogenetics, multimodal imaging, and therapeutic options
Sukhum Silpa-archa, Narumol Silpa-archa, Janine M. Preble, C. Stephen Foster
Autoimmunity Reviews.2016; 15(8): 809. CrossRef Drug-Induced Ocular Adverse Reactions: Review of the Safety Alerts Issued During the Last Decade
Ana Penedones, Diogo Mendes, Carlos Alves, Francisco Batel Marques
Journal of Ocular Pharmacology and Therapeutics.2015; 31(5): 258. CrossRef Biotherapies in inflammatory ocular disorders: Interferons, immunoglobulins, monoclonal antibodies
D. Saadoun, B. Bodaghi, B. Bienvenu, B. Wechsler, D. Sene, S. Trad, S. Abad, P. Cacoub, L. Kodjikian, P. Sève
Autoimmunity Reviews.2013; 12(7): 774. CrossRef Probable Vogt–Koyanagi–Harada disease with initial unilateral ocular manifestation in a hepatitis C carrier
Nikki Y. Far, David T. L. Liu
Journal of Ophthalmic Inflammation and Infection.2012; 2(4): 235. CrossRef
|